Reverse Mergers

And Other Alternatives to Traditional IPOs

Business & Finance, Economics, Consolidation & Merger
Cover of the book Reverse Mergers by David N. Feldman, Steven Dresner, Wiley
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: David N. Feldman, Steven Dresner ISBN: 9780470885499
Publisher: Wiley Publication: May 14, 2010
Imprint: Bloomberg Press Language: English
Author: David N. Feldman, Steven Dresner
ISBN: 9780470885499
Publisher: Wiley
Publication: May 14, 2010
Imprint: Bloomberg Press
Language: English

In good markets or bad, reverse mergers play a key role for companies that want to avoid the IPO route for going public. Since the successful first edition of Reverse Mergers was published in 2006, the economic and regulatory landscape has changed. Executives, owners, lawyers, accountants, professional investors, regulators, and others need to know what those changes mean for reverse mergers.

Reverse-merger expert David Feldman gives an overview of the most important changes since the previous edition was published: new SEC regulations, the changing nature of SPACs (Special-Purpose Acquisition Company), and the emergence of new instruments called WRASPs (WestPark Alternative Senior Exchange Process). The book includes a new chapter on China, and the “Experts Speak” chapter features all new interviewees.

David Feldman is one of the country’s leading experts on reverse mergers, self-filings, and other alternatives to IPOs. His firm has guided hundreds of companies on going public, advising them on structure and mechanics, financing, due diligence, regulatory issues, and more.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In good markets or bad, reverse mergers play a key role for companies that want to avoid the IPO route for going public. Since the successful first edition of Reverse Mergers was published in 2006, the economic and regulatory landscape has changed. Executives, owners, lawyers, accountants, professional investors, regulators, and others need to know what those changes mean for reverse mergers.

Reverse-merger expert David Feldman gives an overview of the most important changes since the previous edition was published: new SEC regulations, the changing nature of SPACs (Special-Purpose Acquisition Company), and the emergence of new instruments called WRASPs (WestPark Alternative Senior Exchange Process). The book includes a new chapter on China, and the “Experts Speak” chapter features all new interviewees.

David Feldman is one of the country’s leading experts on reverse mergers, self-filings, and other alternatives to IPOs. His firm has guided hundreds of companies on going public, advising them on structure and mechanics, financing, due diligence, regulatory issues, and more.

More books from Wiley

Cover of the book Handbook of Bibliometric Indicators by David N. Feldman, Steven Dresner
Cover of the book Alchemists of Loss by David N. Feldman, Steven Dresner
Cover of the book Beton-Kalender 2018 by David N. Feldman, Steven Dresner
Cover of the book Mastering Elliott Wave Principle by David N. Feldman, Steven Dresner
Cover of the book Structural Dynamic Analysis with Generalized Damping Models by David N. Feldman, Steven Dresner
Cover of the book Nanomaterials by David N. Feldman, Steven Dresner
Cover of the book What's Wrong with Money? by David N. Feldman, Steven Dresner
Cover of the book Social Determinants of Health Among African-American Men by David N. Feldman, Steven Dresner
Cover of the book Lead, Sell, or Get Out of the Way by David N. Feldman, Steven Dresner
Cover of the book Marital Communication by David N. Feldman, Steven Dresner
Cover of the book Becoming a Category of One by David N. Feldman, Steven Dresner
Cover of the book A History of Mathematics by David N. Feldman, Steven Dresner
Cover of the book Core Strength For Dummies by David N. Feldman, Steven Dresner
Cover of the book Japanisch für Dummies by David N. Feldman, Steven Dresner
Cover of the book Case Studies in Modern Drug Discovery and Development by David N. Feldman, Steven Dresner
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy